INTRODUCTION
============

*Streptococcus pneumoniae* is responsible for high rates of morbidity and mortality worldwide ([@b14]). This bacterium causes a wide range of pathologies such as pneumonia, meningitis, otitis media, bacteraemia, and other less-frequent infections such as endocarditis and arthritis ([@b5]). Pneumococcal infections are treated with penicillin as the first choice drug, and erythromycin is also frequently used. From 1980, pneumococcal strains began to show a significant increase in resistance rates to penicillin, impeding the control of infections ([@b6]). The resistance rate of *S. pneumoniae* varies with the locality or region studied, and is influenced by the frequency and intensity of utilization, and empirical use of the antimicrobial drugs is frequent ([@b1], [@b2], [@b4]). Because of this evolution of susceptibility of the strains, it is important to carry out constant monitoring of pneumoccocal-related infections. There are many mechanisms of resistance to antimicrobials and with macrolides, the *erm*(B) and *mef*(A/E) genes are responsible for the most-reported mechanisms of resistance to this class. The *erm*(B) gene is known to confer resistance to other antimicrobial classes and a high level of resistance to the macrolides ([@b16], [@b20]).

In 2004 and 2005, 64 strains of *S. pneumoniae* were obtained from three hospitals in Porto Alegre. Identification of *S. pneumoniae* was based on observation of small mucoid colonies, α-hemolytic, cell morphology (Gram-positive diplococci), and sensitivity to optoquine. These strains were isolated from different body fluids including blood, cerebrospinal fluid, and sputum.

Antimicrobial susceptibility was tested by the agar-dilution method according to the NCCLS recommendations, using 5% sheep blood supplementation on Mueller-Hinton-agar ([@b10]). The following antimicrobial drugs were included in the tests: penicillin, erythromycin, tetracycline, chloramphenicol, trimethoprim/sulphamethoxazole, ceftriaxone, and vancomycin (Sigma Chemical, Germany).

Erythromycin-resistant strains were screened for the presence of the *erm*(B) and *mef*(A/E) genes by PCR, using primers and reaction conditions described elsewhere ([@b9], [@b18]). Amplifications were carried out in an Eppendorf thermocycler (Personal Mastercycler) using taq polymerase Invitrogen. DNA was extracted using enzyme treatment and phenolchloroform purifications ([@b15]). Ten susceptible strains to erythromycin and *S. pneumoniae* (ATCC49619) were used as negative controls in the PCR reactions. Two strains of *S. pneumoniae* , 2005 and 1721 (Laboratório de Microbiologia e Parasitologia, UFCSPA) were used as positive controls for the *erm*(B) and *mef*(A/E) genes respectively. All tests were repeated twice.

[Table 1](#tbl1){ref-type="table"} summarizes the antibiotic profiles of *S. pneumoniae* strains resistant to one or more antimicrobials. Of 64 strains, 19% were susceptible to all drugs tested. Resistance to vancomycin was not observed, in accordance with other studies ([@b11]).

###### 

Antibiotic resistance patterns of 52 *treptococcus pneumoniae* strains resistant to one or more antimicrobials.

  Antibiotype[^1^](#tf1-1){ref-type="table-fn"}     Number of resistant strains[^2^](#tf1-2){ref-type="table-fn"}   Number of strains with genotype       
  ------------------------------------------------- --------------------------------------------------------------- --------------------------------- --- ---
  Sut                                               22                                                                                                    
  Sut,Er                                            2                                                               1                                 1   
  Sut,Te                                            4                                                                                                     
  Sut,Ch                                            1                                                                                                     
  Sut,Pen                                           10                                                                                                    
  Sut,Pen,Te                                        2                                                                                                     
  Sut,Pen,Er                                        2                                                               2                                     
  Sut,Pen,Er,Te[^3^](#tf1-3){ref-type="table-fn"}   2                                                               1                                     
  Te                                                3                                                                                                     
  Er                                                2                                                               1                                 1   
  Er,Pen                                            1                                                                                                     1
  Er,Pen,Te,Ch,Cf                                   1                                                               1                                     

Sut: trimethoprim/sulphamethoxazole; Er: erythromycin; Te: tetracycline; Ch: chloramphenicol; Pen: penicillin; Cf: ceftriaxone.

Intermediate and full resistance.

One strain with negative results to *erm*(B) and *mef*(A) gene detection.

The association trimethoprim/sulphamethoxazole showed a high rate of resistance: 7% intermediate resistance (2/38μg/mL) and 61% full resistance (4/76μg/mL). Compared with a preceding study with strains in Brazil, there was an increased number of resistant strains, similar to the situation in other countries ([@b8], [@b13]) and should not be recommended to treat pneumococcal infections.

Forty-six strains (72%) were susceptible to penicillin with a minimum inhibitory concentration (MIC) ≤0.06μg/mL. Among the resistant strains, 20% showed intermediate resistance (between 0.12 and 1μg/mL) and 8% showed full resistance (≥2μg/mL). These results showed that the local and national rates of penicillin resistance are stable compared to the results of other investigators, who reported rates of 26% ([@b3], [@b22]), and still can be considered a good option to control pneumococcal infection. As observed by other workers, among penicillin-resistant strains, multi-drug-resistant strains predominated (strains resistant to at least three classes of drugs, 39%, 7 of 18 strains), compared with susceptible strains that showed concomitant resistance to a maximum of two drugs ([Table 1](#tbl1){ref-type="table"}) ([@b21]). It is important to note that patients infected whith penicillin-resistant strains stayed more days hospitalized compared to those infected with susceptible strains ([@b19]).

We observed a rate of tetracycline resistance below that reported in another study with Brazilian strains (32%) ([@b7]). Seven strains showed intermediate resistance (14%, 4μg/mL), and three strains showed full resistance (4%, ≥8μg/mL). Of these tetracycline-resistant strains, five were multi-resistant ([Table 1](#tbl1){ref-type="table"}). These results indicate that the empirical use of tetracycline in pneumococcal infections is limited.

With chloramphenicol, only 3% of the strains were resistant, with two fully resistant strains (8μg/mL). Similarly low percentages were also observed in Belo Horizonte, Brazil ([@b8]) and in other countries ([@b21]).

Of the 64 strains, only 15% (N=10) showed full resistance to erythromycin (≥1μg/mL). Of these resistant strains, four were susceptible to penicillin, and six were resistant ([Table 2](#tbl2){ref-type="table"}). The rate of resistance to erythromycin was slightly increased, compared to results previously obtained with strains from Porto Alegre and other localities ([@b2], [@b9]). However, these numbers are below those reported in other countries, where rates up to 80% have been observed ([@b2], [@b17]).

These 10 resistant strains were analyzed to explore the possibility of a relationship between the observed resistance and the presence of the *erm*(B) and *mef*(A/E) genes. Six of these strains had *erm*(B), two had *mef*(A/E), one had both genes, and one did not have either gene ([Tables 1](#tbl1){ref-type="table"} and [2](#tbl2){ref-type="table"}). With these results, the relationship of these genes to the erythromycin resistance shown by these strains was confirmed. Strains that had *erm*(B) showed MICs between 2 and ≥8μg/mL, and those that had *mef*(A/E) showed MICs between 1 and 2μg/mL ([Table 2](#tbl2){ref-type="table"}). Strains that had both genes showed MICs ≥8μg/mL, as did the strain that lacked these genes. In spite of the small number of erythromycin-resistant strains tested, almost all of the strains that had *erm*(B) showed elevated MICs, compared to those having *mef*(A/E). The *erm*(B) gene confers resistance to other classes of antimicrobials (streptogramines and lincosamines), affecting the therapeutic choice ([@b16]). The majority of strains that had *erm*(B) were penicillin-resistant. Similar observations were reported by other workers ([Table 1](#tbl1){ref-type="table"} and [2](#tbl2){ref-type="table"}) ([@b16]).

We observed that the rate of resistant strains to penicillin and erythromycin is stable compared to earlier results from studies in Brazil. The penicillin-resistant strains showed a tendency for multi-drug resistance, making it difficult to select an appropriate antimicrobial. In the association trimethoprim/sulphamethoxazole, a high prevalence of resistance was observed, and this combination should not be used to treat *S. pneumoniae* infections. In erythromycin-resistant strains, a correlation between resistance and the presence of *erm*(B) and *mef*(A/E) was demonstrated, with the predominance of the former gene. Also, it is important to note that 30% of penicillin-resistant strains were also eritromycin-resistant, and that almost all erytromycin-resistant strains had a *erm*(B) gene witch, besides the cross resistance to other drugs, leads to a high-level of resistance to such antimicrobials ([@b12], [@b16]).

###### 

Minimum inhibitory concentration (MIC) with erythromycin-resistant strains of *S. pneumoniae* correlated with penicillin resistance.

  Strains   Erythromycin-resistant                 Penicillin-susceptibility          
  --------- -------------------------------------- --------------------------- ------ ---
  1614      *erm*(B)                               2                           0.06   S
  1574      *erm*(B)                               2                           0.5    I
  1530      *erm*(B)                               4                           0.25   I
  1603      *erm*(B)                               4                           1      I
  1652      *erm*(B)                               \>8                         0.03   S
  1575      *erm*(B)                               \>8                         2      R
  1558      *erm*(B)/ *mef*(A/E)                   \>8                         0.12   I
  1557      *mef*(A/E)                             2                           0.06   S
  1514      *mef*(A/E)                             1                           0.06   S
  1520      --[^2^](#tf2-2){ref-type="table-fn"}   \>8                         2      R

I= intermediate resistance; S= susceptible; R= full resistance.

Negative for both genes.
